AstraZeneca and Oxford University have applied for authorisation for their coronavirus vaccine in the European Union with a decision possible by January 29, The European Medicines Agency said on Tuesday.
The jab would be the third available for the 27-nation EU after the Pfizer-BioNTech and Moderna drugs, as the bloc struggles to speed up the rollout.
“EMA has received an application for conditional marketing authorisation for a COVID-19 vaccine developed by AstraZeneca and Oxford University,” the Amsterdam-based regulator said in a statement.
The EMA said its assessment would “proceed under an accelerated timeline”.
- 3 Steps Could Nearly Eliminate COVID Infections on College Campuses: Study - January 15, 2021
- एनसीसी केडेट्स के लिये आज का दिन गौरवशाली - January 15, 2021
- British PM tells public to stay home as deaths soar - January 15, 2021
- Pharmacy Chains Ready to Supply COVID-19 Vaccines to Americans - January 15, 2021
- New COVID-19 treatment trial results published - January 15, 2021
- Health Highlights: Jan. 15, 2021 - January 15, 2021
- मुख्यमंत्री श्री चौहान सिंगरौली से करेंगे प्रदेश में कोरोना वैक्सीन टीकाकरण का शुभारंभ - January 15, 2021
- What Are the Four Types of Neck Dissection? Purpose - January 15, 2021
- Making a hospital space feel psychologically safer helped South African health workers - January 15, 2021
- UPL Limited Urgent Opening for Production Utility Operator Instrument Technician Fitter Apply Now - January 15, 2021